![Marco Sardina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marco Sardina
Direttore/Membro del Consiglio presso
Amypopharma Srl
Profilo
At Panakes since 2021, physician by education and training, with a PhD in Clinical Pharmacology, Marco brings over thirty years of international experience, in leading clinical research projects from Phase I to IV, R&D, Medical Affairs team, supporting Business Development and in/out licensing processes.
Well-recognized expert in drug discovery & development with proven record of advancing projects from discovery to proof-of-concept in clinical stage and marketing approval in different fields.
He has three-year experience as Partner in a Corporate Venture company and 5 years as CSO in BiovelocITA an innovative Biotech focused accelerator.
Marco is Scientific Advisory Board member in innovative startups, author of more than 140 scientific publications and four patents.
He is Fellow of the International College of Angiology, member of the Faculty of Pharmaceutical Medicine and of the New York Academy of Sciences.
Education
M.D.
University of Milan PhD Pharmacology University of Pavia
Posizioni attive di Marco Sardina
| Società | Posizione | Inizio |
|---|---|---|
Amypopharma Srl
 Amypopharma Srl BiotechnologyHealth Technology Operates as a biotech start-up company that develop functionalized nanoliposomes for new therapeutic approaches to treat protein misfolding disorders | Direttore/Membro del Consiglio | - |
Panakes Partners SGR SpA
 Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners invests in small and mid-market companies located across the globe primarily in Europe. The firm targets companies operating in the life sciences sector. It participates in early stage capital requirements. | Investitore di Private Equity | 01/06/2021 |
Precedenti posizioni note di Marco Sardina
| Società | Posizione | Fine |
|---|---|---|
Ciba-Geigy Denmark | Corporate Officer/Principal | - |
Knoll International SpA
 Knoll International SpA Home FurnishingsConsumer Durables Designs and manufactures home and office furniture & furnishings products | Corporate Officer/Principal | - |
Italfarmaco SpA
 Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| NICOX SA | Corporate Officer/Principal | - |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formazione di Marco Sardina
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Ciba-Geigy Denmark | |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Knoll International SpA
Knoll International SpA Home FurnishingsConsumer Durables Designs and manufactures home and office furniture & furnishings products | Consumer Durables |
Panakes Partners SGR SpA
Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners invests in small and mid-market companies located across the globe primarily in Europe. The firm targets companies operating in the life sciences sector. It participates in early stage capital requirements. | Finance |
BiovelocITA Srl
 BiovelocITA Srl Investment ManagersFinance Biovelocita invests in startups located in Italy. The firm focuses on the biotech sector. It provide financing for early stage capital requirements. | Finance |
Amypopharma Srl
Amypopharma Srl BiotechnologyHealth Technology Operates as a biotech start-up company that develop functionalized nanoliposomes for new therapeutic approaches to treat protein misfolding disorders | Health Technology |
Universita Degli Studi Del Sannio
 Universita Degli Studi Del Sannio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Università Di Pavia
 Università Di Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
